The most common ABCB1 variants are 1236C > T, 2677G > T, 3435C > T and have been associated with clinical response to imatinib in chronic myelogenous leukaemia (CML) in some studies. The gene discussed is ABCB1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.